David J Woodhouse Ngm Biopharmaceuticals Inc (NGM) insider trading activity

David J Woodhouse is Chief Executive Officer of NGM BIOPHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of NGM, which is worth approximately $0. The most recent transaction as insider was on Apr 05, 2024, when has been sold 23,993 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

DAVID J WOODHOUSE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 05 2024	SELL Disposition due to a tender of shares in a change of control transaction	-	23,993 Reduced 100.0%	0 Common Stock
Jan 16 2024	SELL Payment of exercise price or tax liability	$17,462 $1.34 p/Share	13,032 Reduced 9.0%	131,822 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	127,200 Added 46.76%	144,854 Common Stock
Dec 29 2021	BUY Exercise of conversion of derivative security	$139,820 $7.92 p/Share	17,654 Added 50.0%	17,654 Common Stock
Nov 18 2021	SELL Open market or private sale	$300,300 $20.02 p/Share	15,000 Reduced 100.0%	0 Common Stock
Nov 18 2021	BUY Exercise of conversion of derivative security	$113,100 $7.54 p/Share	15,000 Added 50.0%	15,000 Common Stock

Also insider at

SRZN

Surrozen, Inc. Healthcare

DJW